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Mexico
Inflammatory response is key for the host defense against diarrheagenic
Escherichia coli and contributes to the pathogenesis of the disease but there is
not a comparative study among different diarrheagenic pathotypes. We analyzed the
inflammatory response induced by five diarrheagenic pathotypes in a HT-29 cell infection
model. The model was unified to reproduce the pathogenesis of each pathotype.
To compare the inflammatory responses we evaluated: (i) nuclear NF-κB and ERK1/2
translocation by confocal microscopy; (ii) kinetics of activation by each pathway detecting
p65 and ERK1/2 phosphorylation by Western blotting; (iii) pathways modulation through
bacterial infections with or without co-stimulation with TNF-α or EGF; (iv) cytokine profile
induced by each pathotype with and without inhibitors of each pathway. EHEC but
mainly EPEC inhibited translocation and activation of p65 and ERK1/2 pathways, as
well as cytokines secretion; inhibition of p65 and ERK1/2 phosphorylation prevailed in
the presence of TNF-α and EGF, respectively. Intracellular strains, EIEC/Shigella flexneri,
caused a strong translocation, activation, and cytokines secretion but they could
not inhibit TNF-α and EGF stimulation. ETEC and mainly EAEC caused a moderate
translocation, but a differential activation, and high cytokines secretion; interestingly
TNF-α and EGF stimulation did no modify p65 and ERK1/2 activation. The use of
inhibitors of NF-κB and/or ERK1/2 showed that NF-κB is crucial for cytokine induction
by the different pathotypes; only partially depended on ERK1/2 activation. Thus, in
spite of their differences, the pathotypes can also be divided in three groups according
to their inflammatory response as those (i) that inject effectors to cause A/E lesion,
which are able to inhibit NF-κB and ERK1/2 pathways, and cytokine secretion; (ii) with
fimbrial adherence and toxin secretion with a moderate inhibition of both pathways but
high cytokines secretion through autocrine cytokine regulation; and (iii) the intracellular
bacteria that induce the highest pathways activation and cytokines secretion by using
different activation mechanisms. This study provides a comprehensive analysis of how
the different pathogenesis schemes of E. coli pathotypes manipulate inflammatory
signaling pathways, which leads to a specific proinflammatory cytokine secretion in a
cell model infection that reproduce the hallmarks of infection of each pathotype.
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INTRODUCTION
Diarrheal diseases are responsible of approximately 800,000
deaths per year in children under 5 years old and represent 10% of
deaths worldwide (Liu et al., 2012) and the second cause of death
(Lanata et al., 2013). Rotavirus, calicivirus, enteropathogenic,
and enterotoxigenic Escherichia coli cause more than a half of
all deaths by diarrhea in children under 5 years old (Lanata
et al., 2013). There are six main pathotypes of diarrheagenic E.
coli: enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli
(EHEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli
(EAEC), diffusely adherent E. coli (DAEC), and enteroinvasive
E. coli (EIEC). The clinical symptoms of each pathotype differ,
as well as colonization site, infection mechanism, and thereby
the induced diseases are different (Croxen et al., 2013), this
exemplifies the E. coli diversity, which includes intra and
extracellular pathotypes. Diarrheagenic E. coli pathotypes secrete
diverse toxins, effectors and virulence factors for exploiting host
cell functions for their colonization. E. coli pathotypes can be
grouped by some similarity in their pathogenic mechanisms.
EPEC and EHEC are grouped as pathogens that induced an
intestinal lesion, named attaching and effacing lesion (A/E
lesion). A/E pathogens are intimately adhered to intestinal
epithelial cells (IECs), causing localized elimination of microvilli
and accumulation of cytoskeletal proteins underneath adhered
bacteria, called pedestals (McDaniel et al., 1995). EHEC is
distinguished from EPEC by the presence of the Shiga toxin
(Stx), which is cytotoxic and responsible for the fatal hemolytic
uremic syndrome (Croxen et al., 2013). ETEC and EAEC are
a common cause of travelers’ diarrhea; ETEC is defined for
elaborating the heat-labile enterotoxin (LT) and/or the heat-
stable enterotoxin (ST; Huang et al., 2004), and EAEC has been
defined by its phenotype of aggregative adherence to HEp-2 cells
(Nataro et al., 1995). EAEC produces enterotoxic and cytotoxic
effects such as intestinal crypts dilatation, enterocytes rounding,
and extrusion (Estrada-Garcia and Navarro-Garcia, 2012). EIEC
is phylogenetically closely related to Shigella spp. and have a
virulence plasmid (pINV), which is essential for the invasive
phenotype (Croxen et al., 2013). However, the infection induced
by EIEC is lesser severe than that induced by Shigella (DuPont
et al., 1989), which has been associated to a low expression of
virulence factors by EIEC on the host cell (Moreno et al., 2009).
Diarrheagenic E. coli provide an interesting model to study
the inflammatory response induced by enteropathogens, since
E. coli strains have acquired diverse mobile genetic elements
due to their genome plasticity, which allows having different
pathotypes in the same bacterial species. Besides, all pathotypes
have diverse pathogen-associated molecular patterns (PAMPs)
that are recognized by pattern recognition receptors (PRRs). IECs
work as sensors detecting PAMPs, through PRRs, as extracellular
and intracellular receptors: Toll-like receptors (TLRs) and NOD-
like receptors (NLRs; Kagnoff and Eckmann, 1997). PRRs
stimulation activates signaling cascades of nuclear factor κB
(NF-κB) and mitogen activated protein kinases (MAPK), which
are fundamental for an effective immune response. NF-κB
p65/p50 complex is known as the classical o canonical pathway
that regulates gene expression involved in the inflammatory
response (Gasparini and Feldmann, 2012). NF-κB is in inactive
form in the cytoplasm by binding to the inhibitory protein,
IκB. Stimulation by various inductors activates a signaling
cascade that culminates in IκB phosphorylation resulting in
IκB degradation. NF-κB is released and translocated into the
nucleus, where it activates various genes that together regulate the
inflammatory response (Kawai and Akira, 2010). Activation of
NF-κB is dependent onMAPKs that are central in various cellular
responses including cytokines regulation. There are three main
groups of MAPKs: ERK1/2, JNK, and p38. ERK1/2 are activated
by MAP kinase kinase (MKK) and MKK2, JNK by MKK4 and
MKK7, and p38 by MKK3, MKK4, and MKK6. After activation
of MAPKs, transcription factors in the cytoplasm or nucleus are
phosphorylated and activated, leading to the gene expression as a
cellular response (Arthur and Ley, 2013).
Inflammatory response studies by each diarrheagenic
pathotype have been performed in different epithelial cell
lines and infection conditions, which have led to a particular
inflammatory response and sometimes the cell models are
inappropriate for comparing the diverse inflammatory responses;
in term of protein expression, receptors, inflammatory mediators
among other characteristics (Sanchez-Villamil and Navarro-
Garcia, 2015). For instance, Elewaut et al. showed differences
in the degradation activity on IκBα and IκBε among cell lines
(Caco-2, HT-29, or T84 cell) infected with EIEC, as well as
different inflammatory responses in these cells stimulated
by TNF-α (Elewaut et al., 1999). Additionally, there are not
studies for comparing the inflammatory responses induced
by the different E. coli pathotypes under similar conditions,
even though many works in an individual way claim a strong
induction of the inflammatory response by these pathotypes.
Thus, a fundamental question is how the life-style of each
pathotype influences the inflammatory response independently
to belong of the same species, which can lead to a particular
intestinal cytokine microenvironmental. In this work, we
developed an intestinal epithelial cell model to study pro-
and anti-inflammatory responses induced by the different
diarrheagenic E. coli pathotypes. This standardized cell model
allowed us to compare the different inflammatory responses
induced in epithelial cells showing the phenotypic hallmark by
the infection with each pathotype. The inflammatory response
induced by each pathotype was different regarding to nuclear
translocation of phosphorylated p65 (NF-κB) and p44 and
p42 (ERK1/2) as well as their kinetics of phosphorylation,
modulation of the stimulus with TNF-α (NF-κB), and EGF
(ERK1/2) and cytokines secretion in the presence or absence of
inhibitors for NF-κB and ERK1/2.
MATERIALS AND METHODS
Bacterial Strains
Bacterial strains used in this study are described in Table 1.
Extracellular bacterial strains were preserved at −70◦C in LB
with 10% glycerol and intracellular bacteria were grown in
TSB (tryptic soy broth). For each experiment, bacteria were
inoculated in LB or TSB and incubated overnight at 37◦C.
Before cell infection, the overnight cultures were activated in
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TABLE 1 | Bacterial strains used in this study.
E. coli pathotype Strain Description Adhesion References
EPEC E2348/69 Prototypical EPEC O127:H6 Attaching and effacing Levine et al., 1978
EHEC EDL933 Prototypical EHEC O157:H7 Attaching and effacing Riley et al., 1983
ETEC H104O7 Prototypical ETEC O78:H11 CF mediated Evans et al., 1975
EAEC O42 Prototypical EAEC O44:H18 Stacked brick Nataro et al., 1995
EIEC E11 Prototypical EIEC O124:NM Invasive DuPont et al., 1971
Shigella spp.
S. flexneri 2457T Serotype 2a Invasive Labrec et al., 1964
Non-pathogenic
E. coli K12 HB101 Non-pathogenic K12 strain NA Boyer and Roulland-Dussoix, 1969
NA, not applicable.
DMEM medium without fetal bovine serum (FBS) and without
antibiotics and incubated for 2 h at 37◦C in static.
Cell Lines
The HT-29 human colorectal adenocarcinoma cell line (ATCC
HTB-38) was grown in DMEM (Gibco, life technologies,
Carlsbad, CA, USA) supplemented with 0.1 mM non-essential
amino acids, 100 U of penicillin/ml, 100 µg of streptomycin/ml,
and 10% FBS (Biowest, Nuaillé, France). The THP-1 human acute
monocytic leukemia cell line (ATCC TIB-202) was cultured in
RPMI 1640 medium with 100 U of penicillin/ml and 100 µg of
streptomycin/ml and 10% FBS. Both cell lines were incubated
at 37◦C in a 5% CO2 incubator. THP-1 cells were differentiated
into macrophage-like cells with 10 ng/ml of phorbol 12-myristate
13-acetate (PMA; Sigma-Aldrich) during 48 h.
Infection Model
For Analysis by Confocal Microscopy
HT-29 cells were cultured in Labtek slides (VWR, Batavia, IL,
USA) and incubated for 48 h to reach a 90% of confluence.
Cells were washed and then were starved by adding DMEM
without FBS and antibiotics and then incubated for another
24 h as a standard method to avoid undesired stimulation
by serum components. Before interaction, cells were washed
and kept in DMEM without FBS and antibiotics. Cells were
inoculated with the corresponding bacterial cultures at a
multiplicity of infection (MOI) of 10 and incubated for 4
h. After the infection, cells were washed and fixed with 4%
paraformaldehyde-PBS, and permeabilized with 0.1% Triton
X-100-PBS. Polymerized actin was detected by staining with
tetramethyl rhodamine isothiocyanate-phalloidin (Molecular
Probes-Invitrogen, Carlsbad, CA, USA). DNA from nuclei and
bacteria were detected using TO-PRO-3 (Molecular Probes-
Invitrogen, Carlsbad, CA, USA).
For Immunofluorescence Analysis
Treated cells were fixed and permeabilized and then were
blocked with 1% bovine serum albumin (BSA). Subsequently,
activated NF-κB and ERK1/2 were detected by incubating the
cells with anti-phospho-p65 or anti-phospho-ERK1/2 antibodies
(Cell signaling Technology, Danvers, MA, USA) as indicated
by the manufacturer, followed by FITC-goat anti-rabbit IgG
and FITC-goat anti-mouse IgG antibodies, respectively, (Thermo
Fisher Scientific, Waltham MA, USA). Slides were mounted
with VectaShield (Vector Laboratories, Burlingame, CA, USA)
covered with glass coverslips and analyzed using a Leica Confocal
Microscope TCS SP8 (Leica Microsystems, Wetzlar, Germany)
and Leica LAS AF lite software. Maximal projections from about
30 sections of 0.4 µm are shown.
For Kinetics of Infection and Immunoblot
Starved cells that had been cultured in 30 × 10 mm
dishes (Corning, NY, USA) were washed and kept in DMEM
without FBS and antibiotics. Cells were inoculated with the
corresponding bacterial cultures at a MOI of 10 and incubated
for 30 min, 1, 2, and 4 h. Mock conditions were cells that
received only the interaction medium without bacteria. After the
infection, cells were washedwith washing buffer (20mMGlycerol
3-phosphate and 20 mMNaF), scraped with 200 µl of lysis buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
IGEPAL, 1% Sodium deoxycholate, 10 mM Na4P2O7, 10 mM
NaF, 10 mM Na3VO4, protease inhibitor cocktail, Complete
TM
)
for 15 min on ice and centrifuged (21,255 × g, 15 min at 4◦C).
Proteins from supernatants were quantified by the Bradford
method and analyzed by immunoblot. Equal amounts of proteins
were loaded on 10% SDS-PAGE gel and transferred to the PVDF
membrane. Membranes were reacted with antibodies against
phospho-ERK1/2, total ERK1/2, phospho-IκB-α, total IκB-α,
total p65, or phospho-p65 (Cell signaling Technology, Danvers,
MA, USA) and actin (a gift from Dr. José Manuel Hernández,
a monoclonal antibody produced at the CINVESTAV) followed
by HRP-conjugated rabbit anti-mouse IgG2a antibody or HRP-
conjugated goat anti-rabbit IgG antibody. Protein bands density
was quantified using Image J, NIH Software.
Co-stimulation Assays
After the infection as mentioned above, cells were washed and
incubated with fresh medium supplemented with 100 µg/ml of
Gentamicin at 37◦C for 1 h in a 5% CO2 incubator. After killing
the bacteria, cells were washed and themediumwas replaced with
fresh DMEMwith 10 ng/ml of either TNF-α or EGF (PeproTech,
Inc., Rocky Hill, NJ, USA) for 10 min. Cells were collected
and lysed as mentioned above. Proteins from supernatants were
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quantified by the Bradford method and analyzed by immunoblot
as mentioned in the previous section.
Determination of Cytokine Concentrations
in Epithelial Cells
Pro-inflammatory cytokines levels (IL-8, TNF-α, IL-1β, IL-6, and
anti-inflammatory IL-10) were simultaneously measured by flow
cytometry using human inflammatory cytokines (CBA) kit (BD
Cytometric Bead Array, Biosciences Pharmingen, San Diego,
USA). All procedures were done following the manufacturer’s
instruction. The data acquisition was performed using a flow
cytometer (BD LSR FortessaTM). Cytokines were quantitatively
measured in culture supernatants from HT-29 cells inoculated
with the different E. coli pathotypes or the non-pathogenic
strain HB101 at a MOI of 10 during 30 min, 1, 2, or 4 h or
treated with 100 ng/ml of lipopolysaccharide (LPS) from E. coli
serotype 0128:B12 (Sigma-Aldrich, St Louis, Missouri, USA).
The quantitative results were generated using the software FCAP
ArrayTM version 3.0 (Soft Flow Hungary Ltd.,).
Determination of Cytokine Concentrations
in Macrophage-Like Cells
After differentiation into THP-1 macrophage-like, cells were
washed and RPMI-1640 without supplements was added and
starved in the same medium for 24 h at 37◦C in a 5% CO2
incubator. THP-1 cells were inoculated with the corresponding
bacterial cultures at a MOI of 10 during 2 and 4 h or treated with
100 ng/ml of LPS during 4 h. Culture supernatants were collected
and analyzed by flow cytometry using human inflammatory
cytokine (CBA) kit as mentioned above.
Inhibitors
The NF-κB pathway inhibitor (BAY 11-7082) and the ERK1/2
pathway inhibitor (PD98059) (PeproTech, Rocky Hill, NJ, USA)
were stored in dimethyl sulfoxide (DMSO) at−20◦C. Prior to the
infection, the cells were incubated with either BAY 11-7082 (100
µM) or PD98059 (100 µM), or both for 1 h. The inhibitors were
maintained during the infection period.
Statistical Analysis
Data representmeans± SEM.Data comparisons were performed
with two-way ANOVA tests and post-hoc Tukey test or Student’s
t-test using GraphPad Software (La Jolla, CA, USA). Differences
were considered significant at p ≤ 0.05.
RESULTS
Reproduction of the Phenotypic Features
Induced by the Different Pathotypes in a
Standardized Epithelial Cell Model
In order to evaluate and compare the inflammatory responses
induced by each pathotype, we first standardized an intestinal
epithelial cells (IECs) model, which could reproduce phenotypic
features induced by each pathotype, such as adhesion,
cytotoxicity, and actin cytoskeleton rearrangements. To do
that, HT-29 cells were infected with the different pathotypes at
different multiplicity of infection (MOI) and different infection
times (data not shown). We found that 4 h of infection at a
MOI of 10 were the optimal conditions to evaluate bacteria
adhesion, cytotoxicity and actin cytoskeletal rearrangement and
these conditions were reproducible for each pathotype. By using
these conditions, HT-29 cells were infected with the different
pathotypes and the infected cells were prepared for confocal
microscopy. Mock cells were observed with a homogeneous
morphology (data not shown), firmly adhered and extended
cells forming compact colonies, showing their integral actin
stress fibers as detected by F-actin assay (FAS). Cells treated
with HB101, a non-pathogenic strain, were also observed with a
normal morphology as the mock cells, without bacterial adhesion
or actin stress fibers disruption (Figures 1, 2). In cells infected
by EPEC, it was possible to observe the characteristic localized
adherence pattern forming bacterial microcolonies, as detected
by bacterial DNA using TO-PRO-3, and the accumulation
of polymerized actin beneath the site of bacterial attachment
to form a pedestal-like structure detected by FAS. In cells
infected by EHEC, bacterial adhesion was observed but without
localized adherence. Most of the adhered bacteria were observed
forming pedestal-like structures. ETEC was unable to cause clear
morphological changes in HT-29 cells but it was possible to
detect randomly bacterial adhesion without actin cytoskeleton
disruption. EAEC was able to adhere in the classic aggregative
adherence pattern, with the typical stacked-brick binding
pattern. Morphological changes were detected as discrete zones
of discontinued actin stress fibers as well as irregular actin
accumulation. On the other hand, the intracellular bacteria,
EIEC, and Shigella flexneri (used as a positive control), caused
the most evident morphological changes by inducing strong
actin cytoskeleton damage. Bacteria were observed adhered to
the plasma membrane and inside the cells and these intracellular
bacteria were seen forming F-actin comet tails (Figures 1, 2). All
these data allowed us to validate the HT-29 cells as an infection
model for the induction of main phenotypic features caused by
the diarrheagenic E. coli pathotypes evaluated.
Differential Nuclear Translocation of NF-κB
and ERK1/2 Induced by the Diarrheagenic
Pathotypes
Once validated the infectionmodel, we evaluated next the nuclear
NF-κB translocation in IECs infected by the different pathotypes
through phosphorylated p65 translocation. HT-29 cells were
infected for 4 h with the different pathotypes (MOI of 10)
or treated with TNF-α (inducer control). Infected cells were
stained with rhodamine-phalloidin and TO-PRO-3 to detect F-
actin and DNA from bacteria and eukaryotic cells, respectively.
Mock cells were observed with a homogeneous morphology
without green signal into nuclei indicating no phospho-p65
translocation (data not shown). Phospho-p65 translocation
induced by TNF-α was clearly detected by the anti-phospho-p65
as a green color inside nuclei and a cyan color in the merge
images showing co-localization of DNA (blue) and phospho-p65
(green) (Figure 1). HB101 was able to cause a very slightly p65
translocation. Interestingly, at 4 h of infection EPEC did not
cause phospho-p65 nuclear translocation since phosphoprotein
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FIGURE 1 | Reproduction of the phenotypic features (adhesion,
cytotoxicity and actin cytoskeleton rearrangements) induced by
different E. coli pathotypes and nuclear translocation of NF-κB in
HT-29 cells as intestinal model. HT-29 cells were infected (MOI 10) during 4
h with the different E. coli pathotypes as indicated. As controls, cells were
treated with E. coli HB101, a non-pathogenic strain, or with TNF-α, a NF-κB
translocation inducer. After treatment, cells were washed, fixed and stained
with rhodamine-phalloidin for actin filaments and TO-PRO-3 for DNA
detection, while NF-κB translocation was detected by immunofluorescence
with anti-phospho-NF-κB (phospho-p65) antibodies followed by FITC-goat
anti-rabbit IgG antibodies. The preparations were analyzed and documented
with a confocal microscope (63X). Arrowheads indicate the location of
bacterial adhesion and arrows point out cytoskeleton rearrangements
(pedestal formation induced by EPEC, EHEC), rounding cell (EAEC), and cell
invasion (intracellular actin tails by EIEC and S. flexneri). Bar 15 µm.
FIGURE 2 | Reproduction of the phenotypic features induced by
different E. coli pathotypes and nuclear translocation of ERK1/2 in
HT-29 cells. HT-29 cells were infected (MOI 10) during 4 h with the different E.
coli pathotypes as indicated. As controls, cells were treated with E. coli
HB101, a non-pathogenic strain, or with EGF, an ERK1/2 translocation
inducer. After treatment, cells were processed for confocal microscopy as
indicated in Figure 1, but ERK1/2 translocation was detected by
immunofluorescence using anti-phospho-ERK1/2 antibodies followed by
FITC-goat anti-mouse IgG antibodies. Arrowheads indicate the location of
bacterial adhesion and arrows point out cytoskeleton rearrangements
(pedestal formation induced by EPEC, EHEC), rounding cell (EAEC), and cell
invasion (intracellular actin tails by EIEC and S. flexneri). Bar 15 µm.
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was undetectable into nuclei. EHEC induced slight phospho-p65
nuclear translocation at 4 h of infection and DNA/phospho-p65
co-localization was less evident; interestingly, this translocation
was lower where enriched pedestal-like structure zones were
localized (Figure 1). On the other hand, ETEC and EAEC showed
a clear homogeneous phospho-p65 nuclear translocation and in
both cases the DNA/phospho-p65 co-localization was evident in
all cell nuclei. In cells infected by intracellular bacteria (EIEC
and S. flexneri), it was also possible to detect phospho-p65
translocation inside nuclei and in both cases the DNA/phospho-
p65 co-localization was also evident; however, both effects were
higher in cells infected with EIEC (Figure 1).
By using a similar approach, we evaluated ERK1/2 nuclear
(phospho-ERK1/2) translocation in IECs infected by the different
pathotypes. HT-29 cells were infected for 4 h with the different
pathotypes (MOI of 10) or treated with EGF (inducer control).
Again, in EGF-treated cells, phospho-ERK1/2 translocation was
clearly detected by the anti-phospho-ERK1/2 as green color
inside nuclei and cyan color in the merge images showing
co-localization of DNA (blue) and phospho-ERK1/2 (green)
(Figure 2). Contrastingly, mock cells did not show phospho-
ERK1/2 translocation and no green signal was detected into
nuclei (data not shown). As expected, HB101 was unable to
cause ERK1/2 translocation since phospho-ERK1/2 was almost
undetectable. Interestingly, neither EPEC nor EHEC were able
to induce phospho-ERK1/2 translocation inside nuclei and
in both cases this protein was undetectable in the infected
cells, despite the strong cytoskeletal disruption caused by
both pathotypes (Figure 2). ETEC and EAEC caused phospho-
ERK1/2 nuclear translocation, which were more evident in cells
infected with ETEC. Thereby, the DNA/phospho-ERK1/2 co-
localization inside nuclei was more evident in these cells infected
with ETEC; despite EAEC caused more cell damage than ETEC.
On the other hand, both intracellular bacteria, EIEC and S.
flexneri induced phospho-ERK1/2 nuclear translocation and it
was stronger in cells infected by EIEC than by S. flexneri; although
there are more intracellular bacteria in cells infected by S. flexneri
than by EIEC (Figure 2).
All these data indicate than the different pathogenic
schemes and virulence factors of pathotypes caused differential
signal transduction for inducing NF-κB and ERK1/2 nuclear
translocation and suggested that this signal transduction
could be manipulated during the infection by these different
pathotypes. For instance, EPEC does not cause phospho-p65 or
phospho-ERK1/2 nuclear translocation while EHEC does cause
phospho-p65, but not phospho-ERK1/2, nuclear translocation.
Interestingly, a lower nuclear factors translocation was detected
in cells being infected by extracellular bacteria, except for
those infected by ETEC (where the morphological damage were
undetectable).
Pathotypes are Able to Differentially
Manipulate the p65 (NF-κB) Activation
Since the analyses of confocal microscopy were performed
at 4 h of infection with the different pathotypes and to
further understand why these bacteria produce these differential
responses, we performed kinetics of infection using the different
pathotypes and detecting NF-κB activation through detection of
p65 phosphorylation using immunoblot with anti-phospho-p65
antibodies. At the same time to understand any modulation of
NF-κB signal transduction pathway by the different pathotypes,
the cells were co-stimulated with TNF-α after the induction of
p65 phosphorylation by the infection. Thus, we first standardized
the optimal time of p65 phosphorylation by TNF-α and
its correlation with IκB-α phosphorylation and subsequent
degradation (detected by antibodies against phosphorylated IκB-
α and total IκB-α). To do that, HT-29 cells were incubated
with TNF-α (10 ng/ml) at different times (10, 15, 30, 60, 120,
and 240 min) and the phosphorylated proteins (IκB-α and p65)
were detected by immunoblot. In untreated cells total IκB-α is
detected as a thick protein band (no degradation) and there are
no bands detected by anti-phospho-IκB-α or anti-phospho-p65
antibodies. At 10 min of TNF-α treatment, it was possible to
observe phosphorylation of IκB-α, which coincided with IκB-
α degradation (in about 50% respect to untreated cells) and,
as expected, a clear band of phosphorylated p65 was detected
that decreased at 60, 120, and 240 min (Figure 3A). Thus, at 15
min, the bands of phosphorylated IκB-α dramatically decreased
(about 40%)mainly because total IκB-α bandwas also decreasing.
Interestingly, phosphorylated p65 was unchanged at 15 and 30
min. However, at 60 min and with next treatment times, total
IκB-α started again to increase (Figure 3A). Total p65 protein
band did not change in all times tested. Once validated the NF-
κB activation, for subsequent co-stimulation experiments, 10min
of stimulation with TNF-α was used. We initially tested p65
phosphorylation induced by the non-pathogenic E. coliHB101 at
different interaction times (0.5, 1, 2, and 4 h). HB101 was unable
to induce p65 phosphorylation at any time tested and only slight
bands were detected, which represented about 20–30% of p65
phosphorylation induced by TNF-α (positive control), which was
arbitrarily defined as 100% of phosphorylation. Interestingly, co-
stimulation with TNF-α after HB101 infection clearly induced
p65 phosphorylation at 30 min of infection and caused an
increase in 100%, similar to the TNF-α treatment alone. The
phosphorylated p65 levels increased with the infection time
beyond 100%, suggesting a synergistic effect between HB101 and
TNF-α induction (Figure 3B).
By using this standardized approach, we compared kinetics
of p65 phosphorylation induced by the different pathotypes as
well as the effects of the co-stimulation with TNF-α. HT-29 cells
infected with EPEC, which had shown no p65 phosphorylation
at 4 h in confocal microscopy experiments, showed that
indeed there was not p65 phosphorylation band as detected by
immunoblot at 4 h of infection. However, EPEC infection caused
p65 phosphorylation at 0.5 h of infection and it represented
60% of the response induced by TNF-α alone. This response
decreased to 30% at 1 and 2 h of infection. Interestingly, co-
stimulation with TNF-α after 0.5 h of EPEC infection increased
p65 phosphorylation, but this increase (75%) was lower that the
induced by TNF-α treatment alone.Moreover, the co-stimulation
after 1 and 2 h of EPEC infection was decreasing with the time
to 70 and 50%, respectively, until be undetectable at 4 h of
infection (Figure 4A). EHEC caused p65 phosphorylation and
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FIGURE 3 | TNF-α and EGF induce a strong activation of NF-κB and ERK1/2 signaling pathways respectively, but not a non-pathogenic strain, in HT-29
cells. (A,B) Effects of TNF-α and EGF on epithelial cells. HT-29 cells were stimulated with TNF-α or EGF (10 ng/ml) during 10, 15, 30, 60, 120, and 240 min. (C,D)
Effects of E. coli HB101 on epithelial cells and its co-stimulation with either TNF-α or EGF. HT-29 cells were inoculated with the non-pathogenic strain E. coli HB101 at
a MOI of 10 for 0.5, 1, 2, and 4 h and divided into two groups. The first group was directly processed after E. coli HB101 inoculation. In the second group, after
incubation, cells were treated with Gentamicin (100 µg/ml) to kill bacteria for 1 h prior to adding TNF-α (C) or EGF (D) (10 ng/ml) for 10 min. Cellular extracts were
analyzed by Western Blot using primary specific antibodies for NF-κB (phospho-p65, phospho-IκB-α and IκB-α) or ERK1/2 (phospho-ERK1/2 and total ERK1/2) and
actin, following by HRP-goat anti-rabbit IgG or HRP-rabbit anti-mouse IgG2a. Uninfected cells stimulated with TNF-α or EGF represent 100% of activation for NF-κB
(C) or ERK1/2 (D) (as positive controls). All proteins evaluated were normalized with actin. Densitometry analysis shows the means ± SEM for at least three
independent experiments. ***p < 0.001 comparing stimulated versus co-stimulated at each time point, using two-way ANOVA test and post-hoc Tukey test.
the increase of the phosphorylated protein band was about 80%,
compared with those induced by the positive control (TNF-α)
at 0.5 h of infection; this percentage decreased to about 50% at
1 and 2 h of infection until disappearing at 4 h. Unlike EPEC,
cells co-stimulated with TNF-α after 0.5, 1, and 2 h of EHEC
infection reached about 100% of p65 phosphorylation, similar to
the positive TNF-α control. Co-stimulation after 4 h of infection,
only decreased to 30% the p65 phosphorylation; unlike EPEC
that caused a full reduction of p65 phosphorylation after co-
stimulation (Figure 4B). Interestingly, ETEC caused a sustained
p65 phosphorylation at 0.5, 1, 2, and 4 h of infection with an
increase of about 30–50%. In cells co-stimulated after the four
different infection times the increase of p65 phosphorylation
only reached percentages of around 50–60% (Figure 4C). From
all these extracellular bacteria, EAEC was the highest p65
phosphorylation inducer with percentages around 80–95% and
this response was sustained at 0.5, 1, and 2 h of infection until
decreasing to 10% at 4 h of infection. Remarkably, co-stimulation
with TNF-α after 0.5, 1, 2, and 4 h of infection by EAEC,
induced levels of p65 phosphorylation very similar to those
of cells infected without co-stimulation (Figure 4D). On the
other hand, the intracellular bacteria responded quite different
regarding to NF-κB activation measured as p65 phosphorylation.
The EIEC infection caused a strong p65 phosphorylation at 0.5
h of infection, which was higher (125%) than those responses
induced by the positive TNF-α control. This response increased
(160%) at 1 h of infection and reached an increase of 185% at
2 and 4 h of infection with respect to those induced by TNF-α
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FIGURE 4 | NF-κB stimulation by the different E. coli pathotypes on HT-29 cells and its co-stimulation with TNF-α. HT-29 cells were infected with the
different E. coli pathotypes, EPEC (A), EHEC (B), ETEC (C), EAEC (D), EIEC (E), and S. flexneri (F) at a MOI of 10 for 0.5, 1, 2, and 4 h and divided into two groups.
The first group was directly processed after the infection. In the second group, after incubation, cells were treated with Gentamicin (100 µg/ml) to kill bacteria for 1 h
prior to adding TNF-α (10 ng/ml) during 10 min. Cellular extracts were analyzed by Western Blot using primary specific antibodies for NF-κB (phospho-p65) and actin,
following by HRP-goat anti-rabbit IgG antibody. Uninfected cells stimulated with TNF-α (as a positive control). All proteins evaluated were normalized with actin.
Densitometry analysis shows the means ± SEM for at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 comparing stimulated versus
co-stimulated at each time point, using two-way ANOVA test and post-hoc Tukey test. For easy comparison, gray bars indicate infected cells and dark gray those
co-stimulated cells.
alone. Interestingly, co-stimulation after infection at all the
times tested caused a two-fold increase in p65 phosphorylation
(about 200%) that those induced by TNF-α alone (Figure 4E).
S. flexneri caused an increase of p65 phosphorylation in a
time-dependent way with percentages higher than TNF-α alone
(135, 160, 200, and 220% at 0.5, 1, 2, and 4 h, respectively).
Moreover, co-stimulation with TNF-α after S. flexneri infection
caused the highest increase of p65 phosphorylation. At 0.5 and
1 h of infection, the co-stimulation increased levels of p65
phosphorylation to 270%with respect to TNF-α alone and clearly
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higher than those values reached by S. flexneri infection alone.
While, at 2 and 4 h of infection the co-stimulation increased the
levels of p65 phosphorylation to 320 and 340% respect to TNF-α
alone (Figure 4F).
ERK1/2 Activation Is also Differentially
Manipulated by the Different Pathotypes
ERK1/2 activation was initially standardized by using
EGF induction at different times and detecting ERK1/2
phosphorylation as previously described (Jijon et al., 2012)
and then validated after HB101 infection at 0.5, 1, 2, and 4 h.
EGF induced ERK1/2 phosphorylation at 10, 15, and 30 min
of interaction with HT-29 cells but not at 120 and 240 min of
interaction (Figure 3C). Thereby, in subsequent experiments
of co-stimulation and as a positive control, EGF was used at
10 ng/ml for 10 min. HB101 infection did not cause induction
of ERK1/2 phosphorylation at any time tested. Whereas, co-
stimulation with EGF after HB101 infection caused an increment
of ERK1/2 phosphorylation at 100% at the different infection
times tested, similar to those levels induced by the positive EGF
control (Figure 3D).
EPEC only caused a modest increment of ERK1/2
phosphorylation at 0.5 h of infection, but no other infection time
points, representing about 25% of levels induced by the positive
EGF control. Interestingly, co-stimulation with EGF after EPEC
infection decreased ERK1/2 phosphorylation (75, 45, 30, and 0%
at 0.5, 1, 2, and 4 h) in comparison to the co-stimulation after
HB101 infection (100% at all tested times; Figure 5A). EHEC
infection also caused an increase of ERK1/2 phosphorylation
in only 20% at 0.5 h of infection and co-stimulation with
EGF after EHEC infection only increased 50–55% at 0.5, 1,
and 2 h of infection and 30% at 4 h in comparison with EGF
alone (100%; Figure 5B). Unlike A/E pathogens as EPEC and
EHEC, the specific pathogenic scheme of ETEC and EAEC
increased ERK1/2 phosphorylation at late time points (2 h
and/or 4 h of infection). ETEC infection increased ERK1/2
phosphorylation at 2 h (45%) and 4 h (35%) of infection.
Interestingly, co-stimulation with EGF following ETEC infection
blocked ERK1/2 phosphorylation at 0.5 and 1 h of infection,
while at 2 and 4 h only reached 55% of the positive control
(Figure 5C). On the other hand, EAEC infection caused a
strong increase of ERK1/2 phosphorylation only at 4 h (85%).
Remarkably, co-stimulation with EGF after EAEC infection did
not cause an increase in ERK1/2 phosphorylation at 0.5, 1, and
2 h, but at 4 h by increasing similar to ETEC infection alone at
4 h (85%; Figure 5D). In the case of intracellular bacteria, the
kinetics of ERK1/2 activation was different that those induced by
extracellular bacteria. Thus, EIEC induced an increase of 50% of
ERK1/2 phosphorylation at 0.5 h and lower than 20% at 1 and
2 h but 75% at 4 h of infection, while co-stimulation with EGF
after infection, only caused an increase in about 50% at 0.5 and
1 h, and 60 and 70% at 2 h and 4 h, respectively (Figure 5E).
S. flexneri infection only caused an increase of 30, 10, and
25% of ERK1/2 phosphorylation at 0.5, 2, and 4 h of infection,
respectively. Co-stimulation with EGF after S. flexneri infection
did not cause 100% of ERK1/2 phosphorylation, but instead
caused about 50% at all the times tested (Figure 5F). Thus,
lowest responses at 1 and 2 h of infection with the intracellular
bacteria were recovered to 50% by co-stimulating with EGF but
at no time tested the EGF co-stimulation after infection reached
a 100%.
Each Pathotype Induces a Particular
Profile of IL-8 and TNF-α Secretion
In order to know the consequences of NF-κB and ERK1/2
activation induced by the pathotypes in term of cytokines
secretion, we measured the cytokine secretion in the cell culture
media after infection with the different pathotypes (MOI 10) at
0.5, 1, 2, and 4 h of infection. After the infection, cell supernatants
were removed and analyzed using the human inflammatory
cytokines CBA kit and flow cytometry. Even though this kit can
detect six cytokines (IL-8, TNF-α, IL-1β, IL-6, IL-12p70, and IL-
10), we were able to detect only IL-8 and TNF-α in HT-29 cells.
Both A/E pathogens, EPEC and EHEC infection increased the
secretion of IL-8 in a time-dependent manner, but EPEC caused
a significantly lower increase of IL-8 secretion; 0.6, 2.7, 10, and 19
ng/ml at 0.5, 1, 2, and 4 h of infection, respectively, while EHEC
infection caused increases in 0.7, 8, 15.5, and 24.6 ng/ml at 0.5,
1, 2, and 4 h of infection (Figure 6A). Interestingly, EPEC and
EHEC infection induced low secretion of TNF-α at 0.5, 1, and
2 h post-infection with values around 0.0005 ng/ml. However,
at 4 h of infection EHEC caused a sudden increase of TNF-α
secretion in 0.0163 ng/ml vs. those induced by EPEC, 0.0013
ng/ml (around 10 times; Figure 6B). ETEC and EAEC infection
caused similar IL-8 secretion at 0.5 h (around 0.7 ng/ml), 1 h
(around 8 ng/ml), and 2 h (around 14 ng/ml), but at 4 h of
infection, EAEC caused a significant increase of IL-8 secretion
than ETEC (47 vs. 34.2 ng/ml; Figure 6A). Similarly, ETEC and
EAEC only caused a significant increase of TNF-α secretion at
2 h with the same values (0.08 ng/ml). At 4 h of infection,
the response was significantly different; EAEC caused a TNF-α
secretion of 0.33 ng/ml while ETEC infection caused a secretion
of 0.2 ng/ml of TNF-α (Figure 6B). Unlike the extracellular
bacteria, the intracellular bacteria induced similar secretion of IL-
8 and TNF-α. Both EIEC and S. flexneri caused increases in IL-8
secretion in a time-dependent manner; around 0.4 ng/ml at 0.5
h of infection, around 17 ng/ml at 1 h, around 28 ng/ml at 2 h,
and around 42 ng/ml at 4 h of infection (Figure 6A). Similarly,
TNF-α secretion was also analogous between the two intracellular
strains with no response at 0.5 h of infection but at 1, 2, and 4 h
the responses ranging 0.12 and 0.22 ng/ml, without a statistical
difference (Figure 6B).
In summary, EPEC is able to efficiently inhibit IL-8 secretion
in comparison with the other pathotypes at all the times tested. In
a lower degree, EHEC also inhibited IL-8 secretion at all the times
tested in comparison with the intracellular bacteria, and at 4 h of
infection compared with the other pathotypes (except for EPEC).
At 4 h of infection, EAEC was the higher IL-8 secretion inducer
and slightly higher than those induced by S. flexneri. At 1 and
2 h of infection clearly the intracellular bacteria were better IL-8
secretion inducer than the extracellular bacteria (Figure 6A).
Regarding TNF-α, EPEC did not induce TNF-α secretion at any
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FIGURE 5 | ERK1/2 stimulation by the different E. coli pathotypes on HT-29 cells and its co-stimulation with EGF. HT-29 cells were infected with the
different E. coli pathotypes, EPEC (A), EHEC (B), ETEC (C), EAEC (D), EIEC (E), and S. flexneri (F) at a MOI of 10 for 0.5, 1, 2, and 4 h and divided into two groups.
The first group was directly processed after the infection. In the second group, after incubation, cells were treated with Gentamicin (100 µg/ml) to kill bacteria for 1 h
prior to adding EGF (10 ng/ml) during 10 min. Cellular extracts were analyzed by Western Blot using primary specific antibodies for ERK1/2 and
phosphorylated-ERK1/2, following by HRP-rabbit anti-mouse IgG2a antibody. Uninfected cells stimulated with EGF (as a positive control). ERK1/2 activation values
were normalized with total ERK1/2. Densitometry analysis shows the means ± SEM for at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
comparing stimulated versus co-stimulated at each time point, using two-way ANOVA test and post-hoc Tukey test. For easy comparison, gray bars indicate infected
cells and dark gray those co-stimulated cells.
time tested while EHEC only induced a modest response at 4 h of
infection. ETEC induced a modest response at 1 h of infection,
but this response increased to values similar to those induced
by the intracellular bacteria, and for this latter group, the values
were similar at 1, 2, and 4 h of infection. Interestingly, the higher
inducer of TNF-α secretion was again EAEC (Figure 6B).
Since HT-29 cells appeared not to secrete the whole set
of cytokines, which are detected by the human inflammatory
cytokines CBA kit, and in order to investigate if cytokines
response could have a similar profile between epithelial cells
and macrophages regarding the secretion of IL-8 and TNF-
α, we tested the detection of cytokines in PMA-differentiated
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FIGURE 6 | IL-8 and TNF-α secretion induced by the different E. coli
pathotypes in HT-29 cell model. HT-29 cells were infected with the different
E. coli pathotypes (MOI 10) during 0.5, 1, 2, or 4 h. After the infection, cell
supernatants were removed and analyzed using Human inflammatory
cytokines CBA kit (BD Biosciences). Data were acquired on a BD FACS
Fortessa flow cytometer. All IL-8 (A) and TNF-α (B) data are means ± SEM of
the three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
comparing each pathotype by group, using Student’s t-test.
THP-1 cells infected with all pathotypes at a MOI of 10 during
2 and 4 h. Interestingly, the profile of IL-8 secretion detected in
THP-1 macrophage-like cells was very similar to those secreted
by HT-29 epithelial cells; i.e., EPEC and EHEC pathotypes
induced the lower levels of IL-8 secretion (12.3 and 18 ng/ml
at 4 h post-infection vs. 19 and 24.6 ng/ml in HT-29 cells).
These values were even lower that those induced by LPS or
E. coli HB101 (Figure 7A). Remarkably, the profile of TNF-
α secretion by THP-1 macrophages was also similar to those
of HT-29 cells (with the exception of EHEC infection) but
macrophages were more efficient secreting TNF-α than HT-29
cells; i.e., EHEC and mainly EPEC induced the lowest levels
of TNF-α secretion in comparison with the other pathotypes,
as the infected HT-29 cells, but up to1000 fold more TNF-α
secretion than those secreted by HT-29 cells (6.7 and 5.2 ng/ml
vs. 0.0163 and 0.0013 ng/ml; Figure 7B). These data suggest
similar mechanisms of induction in both cell lines, which can
be caused by damping extracellular receptors or intracellular
signaling pathways. Additionally, unlike epithelial cells, THP-1
macrophage-like cells infected with the different pathotypes
were also able to secrete IL-1β, IL-6, and IL-10 (Figures 7C–E).
In general, EPEC and EHEC induced the lower secretion of
these cytokines in comparison to the other pathotypes, while
the intracellular bacteria induced the higher secretion of the
cytokines. Interestingly, EAEC and mainly ETEC induced the
highest levels of IL-6 at 4 h post-infection. These data suggest
that the different E. coli pathotypes also modulate the cytokines
secretion in macrophages.
NF-κB Activation is the Main Contributor of
the IL-8 and TNF-α Secretion Responses
In order to identify the influence of signaling pathways (NF-
κB or ERK1/2) inducing the secretion of epithelial cytokines
upon different pathotypes infection, we used specific inhibitors.
HT-29 cells were preincubated for 1 h with inhibitors of NF-
κB (BAY 11-7082) or ERK1/2 (PD98059) single or combined,
and then cells were infected with the different pathotypes for 2
or 4 h. Supernatants from infected cells were analyzed for IL-8
and TNF-α secretion. Interestingly, blockage of NF-κB pathway
completely inhibited IL-8 and TNF-α secretion induced by all the
pathotypes (Figures 8A,B). On the other hand, the blockage of
ERK1/2 pathway did not cause complete inhibition of IL-8 and
TNF-α secretion, but caused partial and differential inhibition.
Thus, ERK1/2 pathway blockage caused the highest inhibition
of IL-8 secretion induced by EAEC infection at 2 h (73%) and
4 h (63%) of infection, while the lowest inhibition was induced
in cells infected for 2 h by S. flexneri (49%), EHEC (48.5%),
or EIEC (47%), and at 4 h IL-8 secretion was inhibited 74–
64% during infection by ETEC>EHEC>EPEC>EIEC>EAEC,
while lowest inhibition (43%) was during the infection by S.
flexneri. Remarkably, the ERK1/2 pathway inhibition appears to
be compensated by the NF-κB pathway for IL-8 secretion because
the remaining cytokine secretion during ERK1/2 blockage was
completely inhibited by using both inhibitors (BAY 11-7082 and
PD98059). Regarding the TNF-α secretion, blockage of ERK1/2
pathway completely inhibited TNF-α secretion induced by all
the extracellular bacteria (EPEC, EHEC, ETEC, and EAEC) at
2 h of infection, but not those induced by the intracellular
bacteria, whose inhibition were of 39 and 31% for EIEC and S.
flexneri, respectively. Interestingly, inhibition of TNF-α secretion
induced at 4 h by the different pathotypes due to the blockage
of ERK1/2 pathway was less efficient mainly during infection
by S. flexneri (32%), ETEC (33%), EIEC, and EAEC (43%) but
efficiently inhibited during the infection by EHEC (61%) and
EPEC (100%). Again, the remaining values of TNF-α secretion
were completely inhibited when the inhibitors of both pathways
were used.
DISCUSSION
We have developed an infection model of epithelial cells, which
allowed reproduce the phenotypic features reported for the
different diarrheagenic pathotypes using the same infection
conditions such as multiplicity of infection and infection times.
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FIGURE 7 | Infection of human macrophages THP-1 cell line with the different E. coli pathotypes induce a differential cytokine secretion of IL-8, IL-1β,
TNF-α, IL-6, and IL-10. THP-1 cells were differentiated into macrophages-like cells using PMA at a concentration of 10 ng/mL during 48 h. After differentiation,
adherent cells were infected with the different E. coli pathotypes (MOI 10) during 2 or 4 h. After infection, cell supernatants were removed and analyzed using Human
inflammatory cytokines CBA kit. Data were acquired on a BDTM FACS Fortessa flow cytometer. Graphs represent cytokine secretion of IL-8 (A) and TNF-α (B), as
IL-1β (C), IL-6 (D), and IL-10 (E). All data are means ± SEM of the three independent experiments. For statistical comparison, the pathotypes were grouped
according to their way of interacting with the host cell as in Figure 6: *p < 0.05, **p < 0.01, ***p < 0.001 comparing each pathotype group or ∧p < 0.05, ∧∧p <
0.01, ∧∧∧p < 0.001 comparing each pathotype versus non-pathogenic E. coli HB101, using Student’s t-test.
In these cells displaying the phenotypic feature induced by
each phenotype were analyzed the nuclear translocation, kinetics
of activation and modulation of NF-κB and ERK1/2 signaling
pathways induced by different E. coli pathotypes. This model also
allowed determine the outcome of the activation of these nuclear
factors by quantifying the secretion of epithelial cytokines as well
as the role of each signaling pathway by blocking the responses
using inhibitors for NF-κB and/or ERK1/2. Thus, for the first
time this work shows a comparison of inflammatory response of
each pathotype on a specific cell line under the same condition
and ensuring reproducibility of phenotype feature induced by
each pathotype.
HT-29 cells allow reproducing the well-defined adherence
pattern for EAEC, EPEC, and EHEC pathotypes, actin
cytoskeletal rearrangement induced by EPEC and EHEC
(pedestal formation), EAEC (cytoskeletal contraction and
rounding cells), and EIEC/Shigella (intracellular actin tails); as
well as adhesion of ETEC on epithelial cells without apparent cell
damage (Kaper et al., 2004). HT-29 cells have been previously
used in individual way in studies of the inflammatory response
induced by some pathotypes (Sharma et al., 2006; Salazar-
Gonzalez and Navarro-Garcia, 2011; Xue et al., 2014; Ye et al.,
2015). HT-29 cells have several advantages for evaluating the
activation of the inflammatory response regarding to other cell
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FIGURE 8 | Effect of the inhibitors of NF-κB and ERK1/2 in the cytokine
secretion induced by the different E. coli pathotypes. HT-29 cells were
pretreated with inhibitors of NF-κB (BAY 11-7082) or ERK1/2 (PD98059)
pathways or both, during 1 h at a concentration of 100 µM. After treatment,
cells were carefully washed and infected with the different E. coli pathotypes
(MOI 10) during 2 and 4 h. After the infection, the supernatants were removed
and analyzed using Human inflammatory cytokines CBA kit. Data were
acquired on a BD LSR FortessaTM FACS flow cytometer. Graphs represent
cytokine secretion of IL-8 (A) and TNF-α (B). All data are means ± SEM of the
three independent experiments. ***p <0.001 comparing infected versus
pretreated with inhibitors, using two-way ANOVA test and post-hoc Tukey test.
lines from intestinal linage such as Caco-2 and T84 cells. HT-29
cells have been proposed as an ideal model for evaluating the
inflammatory response induced by EPEC than the T84 cells;
produce a robust response of IL-8 secretion (Sharma et al., 2006).
Indeed, here we have shown that HT-29 cell secreted equivalent
levels of IL-8 that professional antigen presenting cells as the
macrophages. Additionally, HT-29 cells express Gb-3, a Shiga
toxin receptor, and are susceptible to Stx, while T84 cells do
not expresses Gb-3 and thereby are resistant to the Stx effects
such as inhibition of protein synthesis and ribotoxic stress
response. This latter effect is relevant since there is upregulation
of pro-inflammatory genes depending on Stx in Gb3-positive
epithelial lines through the ribotoxic stress response (Thorpe
et al., 1999; Smith et al., 2003). Furthermore, it has been
demonstrated that TNF-α-stimulated HT-29 cells induce a
strong NF-κB activation and subsequent IκB degradation, which
did not occur in Caco-2 cells (Elewaut et al., 1999). Thus,
HT-29 cells represent an appropriated model for our aim as
well as to reproduce the specific pathogenesis schemes for each
pathotype.
EPEC and mainly EHEC induced both p65 and ERK1/2
phosphorylation at early times (30 min) of infection. This
correlates with previous studies, in which PAMPs as flagellin
from EPEC (fliC), EHEC (H7), or the hemorrhagic coli pilus
(HCP), promotes the early inflammatory response (Zhou et al.,
2003; Miyamoto et al., 2006; Ledesma et al., 2010). However,
at late times both p65 and ERK1/2 phosphorylation decreased
in a time-dependent manner until it disappears. It has been
described that after 60 min of infection, EPEC injects through
T3SS non-LEE-effectors (Nle; Mills et al., 2013), related to NF-κB
signaling pathway subversion, which could explain the decreased
p65 phosphorylation in our infection model. Interestingly,
p65 and ERK1/2 phosphorylation decrements were related to
the inhibitory ability of these pathotypes, since co-stimulation
experiments showed that EPEC/EHEC prevents TNF-α-induced
p65 phosphorylation and EGF-induced ERK1/2 phosphorylation
post-infection. At 4 h of infection, EHEC partially inhibited
TNF-α-induced p65 phosphorylation and EGF-induced ERK1/2
phosphorylation, while a complete inhibition of both pathways
was observed by EPEC infection. These inhibitory effects
constitute a mechanism to subvert the host immune response
for A/E pathotypes, in which it has been demonstrated that Nle-
effectors cooperatively participate in suppress NF-κB activation;
inhibiting IKKβ phosphorylation (NleE and NleB), (Nadler et al.,
2010; Vossenkämper et al., 2010) or by direct enzymatic digestion
of p65 subunit (NleC; Baruch et al., 2011; Pearson et al., 2011).
Even though EPEC and EHEC have been involved in MAPK
response inhibition, no effectors involved in specific inhibition
of ERK1/2 have been described in EPEC or EHEC. Indeed,
EPEC induces the cleavage of both p38 and JNK in NleD-
dependent manner, but not that of ERK (Baruch et al., 2011).
However, many studies describe a close association between
ERK1/2 activity and an increased nuclear translocation of NF-κB.
For instance, ERK regulates NF-κB activation through increasing
IκB phosphorylation (Dhawan and Richmond, 2002) or NF-
κB DNA binding activity (Briant et al., 1998). These inhibitory
effects could explain the absence of signal translocation of NF-
κB and ERK1/2 detected by confocal microscopy in response to
EHEC and mainly EPEC infection at 4 h. However, although
these pathotypes share many of these effectors, in our model,
EHEC infection induced a slightly nuclear translocation of NF-
κB but not EPEC. This difference might be given by Shiga
toxin (Stx), a hallmark of EHEC, since it has been reported
that Stx activates NF-κB in THP-1 cells (Sakiri et al., 1998).
Thus, EPEC is more efficient than EHEC in subverting the
inflammatory response, even when the EHEC genome encodes
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more than 40 effector proteins (Tobe et al., 2006), and EPEC
encodes at least 21 (Iguchi et al., 2009). These data also might
explain why EPEC infection of humans is not associated with
strong inflammatory responses that compromises integrity of the
epithelial barrier in spite of the strong attaching and effacing
modifications.
While EPEC/EHEC pathotypes employ T3SS-dependent
infection strategies, both ETEC and EAEC pathotypes employ
different strategies, mainly based on their colonization factors
followed by secretion of toxins that subsequently enter the host
cell. It has been shown that ETEC infection activates both NF-
κB and MAPK signaling pathways through mechanisms LT-
dependent in HCT-8 (Wang et al., 2012) and T84 (Chutkan
and Kuehn, 2011) IECs. In our study we also found that ETEC
infection induced p65 phosphorylation from early times and it
is maintained throughout the kinetics of infection. However, in
co-stimulation experiments, ETEC infection appears to secrete
potent anti-inflammatory factor(s), since it inhibited TNF-α-
induced p65 phosphorylation. This inhibitory effect was seen
from 30 min of infection, suggesting that a factor at early times
is responsible for this inhibition. In this sense, the ST toxin
does not need more than 30 min to interact with epithelial cells,
because ST does not need to undergo intracellular traffic; its
receptor is also the catalytic target, the guanylate cyclase (Schulz
et al., 1990). Therefore, this model may be useful to study the
role of ST in the inflammatory response. Contrastingly, EAEC
infection induced strong p65 phosphorylation at early times
comparable to TNF-α-inducedNF-κB activation. This phenotype
has been described in T84 and INT-407 IECs, in which EAEC
infection activates both NF-κB and MAPK signaling pathways
resulting in IL-8 production (Harrington et al., 2005; Khan et al.,
2010), considering this pro-inflammatory response as an essential
role in the EAEC-induced pathology. However, in our infection
model, at late times some factor(s) from EAEC decreased
p65 phosphorylation and this inhibition was kept in TNF-α-
induced p65-phosphorylation. These data suggest the action of
unknown anti-inflammatory factor(s), which probably help to
counteract the exacerbated inflammatory response induced by
this pathotype.
Interestingly and contrary to EPEC/EHEC, both ETEC and
EAEC induced ERK1/2 phosphorylation only at late times (2
and 4 h respectively). These data are similar to those reported
in epithelial cells infected with ETEC (HCT-8 cells) and EAEC
(INT-407 cells; Khan et al., 2010; Wang et al., 2012). But
none of these works mentioned the early inhibition induced
by ETEC and EAEC on ERK1/2 phosphorylation at 30 min
and 1 h post-infection. Furthermore, ETEC and mainly EAEC
inhibited EGF-induced ERK1/2 phosphorylation mainly at early
times. Therefore, this model is useful to identify potential news
proteins or mechanisms related inhibition of ERK1/2 signaling
pathway.
In contrast to extracellular bacteria, intracellular strains EIEC
and mainly S. flexneri induced a strong p65 phosphorylation
beyond the levels of TNF-α-induced p65 phosphorylation;
correlating with the stronger p65 nuclear translocation induced
by both intracellular strains in confocal microscopy experiments.
Interestingly, co-stimulation with TNF-α further increased p65
phosphorylation in a differential way for these two bacteria:
EIEC caused a partial synergistic effect, while S. flexneri caused
a clear synergistic effect. It has been shown that LPS and IpgB2-
OspB effectors from S. flexneri activate NF-κB pathway through
recognition by cytosolic NOD1/CARD4 and NOD1/GEF-H1,
respectively (Girardin et al., 2001; Fukazawa et al., 2008).
Together in our infection model, these data suggest that both
intracellular bacteria promote the NF-κB activation by cytosolic
NLRs independently of the TNF-α-induced p65 phosphorylation.
Besides these intracellular bacteria have no flagellum (Hale,
1991), therefore NF-κB activation is independent of TLR5-
flagellin recognition. On the other hand, S. flexneri and mainly
EIEC induced ERK1/2 phosphorylation at early and late times,
but at intermediate times ERK1/2 phosphorylation drastically
decreased. Co-stimulation experiments showed partial inhibitory
effects in which, EGF-induced ERK1/2 phosphorylation does not
reach 100% but at intermediate times ERK1/2 phosphorylation
was not significantly different of those of late times of
infection. It has been shown that the T3SS effector OspF
from S. flexneri has a phosphothreonine lyase activity that
irreversibly dephosphorylated MAPK (ERK1/2, p38, and JNK;
Li et al., 2007) and OspF is also present in EIEC (Ud-
Din and Wahid, 2014). Interestingly, OspF-induced MAPK
dephosphorylation potentiates the activation of the NF-κB
during S. flexneri infection (Reiterer et al., 2011). Although these
intracellular strains are phylogenetically closely related, here we
showed that S. flexneri is more efficient than EIEC inducing
strong NF-κB activation and suppressing EGF-induced ERK1/2
phosphorylation.
In this model infection EHEC and mainly EPEC induced
the lowest levels of IL-8 and TNF-α secretion compared to the
other pathotypes, which correlated with the inhibitory effects
on NF-κB and ERK1/2 activation. Interestingly, EPEC infection
does not induced TNF-α secretion, which could result in a
decreased inflammatory response (Bradley, 2008) compared to
EHEC. Indeed, EHEC produce a hemorrhagic coli pilus (HCP),
which is a potent inducer of IL-8 and TNF-α release through NF-
κB and MAPK activation (Ledesma et al., 2010). Contrastingly,
ETEC and mainly EAEC induced a strong IL-8 and TNF-
α secretion, even when partial inhibitory effects of signaling
pathways were observed. This difference in IL-8 secretion has
been shown in isolates from patients with travelers’ diarrhea,
in which EAEC causes a greater response of IL-8 than ETEC
(Huang et al., 2004). EAEC infection also induced the highest
levels of TNF-α secretion. Remarkably, some stimuli, such as
IL-1 or TNF, up-regulate IL-8 by more than 100-fold in human
astrocytoma and alveolar epithelial cell lines (Kasahara et al.,
1991; Brasier et al., 1998), suggesting a synergistic effect of
EAEC by inducing high TNF-α and IL-8 secretion. Interestingly,
intracellular strains induced a strong IL-8 and TNF-α secretion
from early times of infection compared with the other pathotypes
(except EAEC infection at 4 h), which correlates to the strong
NF-κB activation and the intestinal pathology caused by these
pathotypes, in spite of the inhibitory effects observed in ERK1/2
phosphorylation. In fact, significantly raised stool TNF-α has
been detected in patients coursing shigellosis (de Silva et al.,
1993). It is important to note that non-pathogenic strain HB101
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did not induce nuclear translocation of NF-κB and ERK1/2 or
modulation of signaling pathways in our infection model. This
indicates that specific pathogenesis scheme of each pathotype
are responsible for inducing the specific inflammatory responses
observed in this model.
Notably, pre-treatment with a specific inhibitor of NF-κB
(BAY 11-7082) completely prevents the IL-8 and TNF-α secretion
induced by the different E. coli pathotypes. While the use of
a specific inhibitor of ERK1/2 (PD98059) partially reduces the
IL-8 secretion, however, it does not efficiently prevent TNF-
α secretion induced by ETEC, EAEC, and mainly intracellular
strains. This suggests that for all E. coli pathotypes, NF-
κB signaling pathway is essential for the cytokine secretion,
and partially dependent on ERK1/2 signaling pathway for
the full induction of proinflammatory cytokine. It has been
demonstrated, that the PD98059 inhibitor attenuates IkB
degradation and the IL-8 expression, demonstrating that NF-
κB activation is dependent on ERK1/2 (Savkovic et al., 2001).
Additionally, it has been demonstrated that ERK1/2 inhibitor
(PD98059) had no effect on LPS-induced TNF-α secretion in
rat vascular smooth muscle cells. However, the p38 inhibitor
(SB203580) partially blocks TNF-α secretion but a complete
inhibition was observed with NF-κB inhibitors (PDTC and
MG132; Yamakawa et al., 1999). All these suggest that in our
model p38 MAPK could regulate TNF-α secretion in response
to E. coli pathotypes infection.
These data together, provides a comprehensive and detailed
analysis that allowed us to compare how the different
pathogenesis schemes of E. coli pathotypes manipulate signaling
pathways related to the inflammatory response, which leads to a
specific proinflammatory cytokine secretion for each pathotype
in a cell model infection (see Figure 9) that reproduce the
hallmarks of infection of each pathotype. Our findings let us to
propose that two events can be playing a role in these differential
responses: an unbalanced response between NF-κB and ERK1/2
pathways and differential secretion of TNF-α, which could
synergize the inflammatory response including IL-8 secretion
(Figure 9).
FIGURE 9 | Summary of the inflammatory responses induced by the different pathotype on epithelial cells. HT-29 cells differentially responded to the
infection by the different pathotypes. In spite of their differences, the pathotype can also be divided in three groups according to their inflammatory response: (i) EPEC
and EHEC that inject effectors to cause A/E lesion, which are able to inhibit NF-κB and ERK1/2 pathways, and cytokine secretion; (ii) EAEC and ETEC with fimbrial
adherence and toxin secretion with a moderate inhibition of both pathways but high cytokines secretion through autocrine cytokine regulation; and (iii) S. flexneri and
EIEC, the intracellular bacteria, that induce the highest pathways activation and cytokines secretion by using different activation mechanisms. The secretion of IL-8 and
TNF-α induced by the different E. coli pathotypes was partially inhibited by ERK1/2 inhibitor (PD98059) and completely inhibited by NF-κB inhibitor (BAY 11-7082).
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